Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma-Reference-Cited by-同舟云学术

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma

Published:2018-04-27 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Manier S.,Park J.,Capelletti M.,Bustoros M.^ORCID,Freeman S. S.,Ha G.,Rhoades J.,Liu C. J.,Huynh D.,Reed S. C.,Gydush G.,Salem K. Z.,Rotem D.,Freymond C.,Yosef A.,Perilla-Glen A.,Garderet L.,Van Allen E. M.^ORCID,Kumar S.^ORCID,Love J. C.^ORCID,Getz G.,Adalsteinsson V. A.,Ghobrial I. M.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-04001-5.pdf

Reference30 articles.

1. Palumbo, A. & Anderson, K. Multiple myeloma. N. Eng. J. Med. 364, 1046–1060 (2011).

2. Manier, S. et al. Genomic complexity of multiple myeloma and its clinical implications. Nat. Rev. Clin. Oncol. 14, 100–113 (2016).

3. Mishima, Y. et al. The mutational landscape of circulating tumor cells in multiple myeloma. Cell Rep. 19, 218–224 (2017).

4. Kis, O. et al. Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates. Nat. Commun. 8, 15086 (2017).

5. Lohr, J. G. et al. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution. Sci. Transl. Med. 8, 363ra147 (2016).

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma;International Journal of Molecular Sciences;2024-08-30

3. Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients;Scientific Reports;2024-08-13

4. Impact of preanalytical factors on liquid biopsy in the canine cancer model;2024-07-30

5. Мутации в генах KRAS/NRAS и эффективность индукционной терапии по трехкомпонентным схемам на основе бортезомиба у пациентов с впервые диагностированной множественной миеломой;Clinical Oncohematology;2024-07-01